Free Trial
→ Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever (From Chaikin Analytics) (Ad)tc pixel Free AKTS Stock Alerts

Aktis Oncology (AKTS) Short Interest Ratio & Short Volume

Aktis Oncology logo
$18.72 -0.12 (-0.64%)
As of 01:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Aktis Oncology Short Interest Overview

As of November 30, 2024, Aktis Oncology (AKTS) had a short interest of 7.25 million shares sold short. This marks a 101.95% increase in short interest since the prior report. The short interest ratio (days to cover) is 0.3, meaning it would take 0.3 days of the average trading volume of 332,280 shares to cover all short positions.

Current Short Interest
7,250,000 shares
Previous Short Interest
3,590,000 shares
Change Vs. Previous Month
101.95%
Dollar Volume Sold Short
$732.25 thousand
Short Interest Ratio
0.3 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
53,400,000 shares
Percentage of Shares Shorted
13.58%
Today's Trading Volume
41,355 shares
Average Trading Volume
332,280 shares
Today's Volume Vs. Average
12%
Short Selling Aktis Oncology?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Aktis Oncology and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AKTS Short Interest Over Time

AKTS Days to Cover Over Time

AKTS Percentage of Float Shorted Over Time

Aktis Oncology Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/20247,250,000 shares $732.25 thousand +102.0%N/A0.3 $0.10
11/15/20243,590,000 shares $227.97 thousand -32.7%N/A0.2 $0.06
10/31/20245,330,000 shares $297.95 thousand +300.8%N/A0.4 $0.06
10/15/20241,330,000 shares $85.92 thousand -5.7%N/A0.1 $0.06
9/30/20241,410,000 shares $126.20 thousand -49.6%N/A0.2 $0.09
9/15/20242,800,000 shares $156.52 thousand -39.7%N/A0.3 $0.06
8/31/20244,640,000 shares $374.91 thousand -45.3%N/A0.6 $0.08
8/15/20248,480,000 shares $756.42 thousand +106.8%N/A0.9 $0.09
7/31/20244,100,000 shares $494.46 thousand -26.8%N/A0.3 $0.12
7/15/20245,600,000 shares $737.52 thousand -8.9%N/A0.4 $0.13
6/30/20246,150,000 shares $809.96 thousand -17.6%N/A0.4 $0.13
6/15/20247,460,000 shares $987.70 thousand -27.9%N/A0.6 $0.13
5/31/202410,340,000 shares $2.22 million +27.3%N/A0.9 $0.22
5/15/20248,120,000 shares $3.38 million -18.6%N/A0.8 $0.42
4/30/20249,970,000 shares $5.85 million +5.1%N/A14.9 $0.59
4/15/20249,490,000 shares $4.99 million +0.5%N/A11 $0.53
3/31/20249,440,000 shares $5.58 million +9.6%N/A10.4 $0.59
3/15/20248,610,000 shares $4.68 million +13.6%N/A9.1 $0.54
2/29/20247,580,000 shares $4.71 million -9.8%N/A8.2 $0.62
2/15/20248,400,000 shares $6.17 million +3.8%N/A9.1 $0.74
1/31/20248,090,000 shares $4.64 million +17.4%N/A9.5 $0.57
1/15/20246,890,000 shares $4.50 million -5.0%N/A10.2 $0.65
12/31/20237,250,000 shares $6.05 million -3.5%N/A11.3 $0.83
12/15/20237,510,000 shares $5.82 million -0.3%N/A11.6 $0.77
11/30/20237,530,000 shares $4.29 million +9.1%N/A10 $0.57
11/15/20236,900,000 shares $5.22 million -2.7%N/A7.3 $0.76
10/31/20237,090,000 shares $3.59 million +1.1%N/A7.6 $0.51
10/15/20237,010,000 shares $5.26 million +9.2%N/A7.5 $0.75
9/30/20236,420,000 shares $4.83 million -3.5%N/A6.5 $0.75
9/15/20236,650,000 shares $5.63 million -7.9%N/A6.9 $0.85
8/31/20237,220,000 shares $10.90 million +9.7%N/A8.5 $1.51
8/15/20236,580,000 shares $12.17 million +15.6%N/A12 $1.85
7/31/20235,690,000 shares $13.60 million +0.5%N/A10.2 $2.39
7/15/20235,660,000 shares $15.57 million +2.5%N/A10.3 $2.75
6/30/20235,520,000 shares $17.55 million +3.2%N/A11.1 $3.18
6/15/20235,350,000 shares $16.59 million -3.4%N/A10.5 $3.10
5/31/20235,540,000 shares $17.51 million -4.0%N/A9.8 $3.16
5/15/20235,770,000 shares $16.91 million +2.9%N/A9.7 $2.93
4/30/20235,610,000 shares $15.99 million +2.9%N/A8.6 $2.85
4/15/20235,450,000 shares $17.33 million -1.8%N/A6.9 $3.18
3/31/20235,550,000 shares $17.09 million +11.7%N/A6.9 $3.08
3/15/20234,970,000 shares $15.75 million +11.7%N/A6.2 $3.17
2/28/20234,450,000 shares $16.64 million +11.0%N/A6.4 $3.74
2/15/20234,010,000 shares $17.00 million -5.9%N/A6.1 $4.24
1/31/20234,260,000 shares $15.72 million -14.1%N/A6.7 $3.69
1/15/20234,960,000 shares $18.35 million +0.8%N/A9.7 $3.70
12/30/20224,920,000 shares $13.87 million +10.6%N/A11.5 $2.82
12/15/20224,450,000 shares $15.00 million -0.9%N/A10.6 $3.37
11/30/20224,490,000 shares $17.06 million -0.9%N/A10.4 $3.80
11/15/20224,530,000 shares $17.44 million -4.2%N/A10.3 $3.85
10/31/20224,730,000 shares $15.75 million -3.9%N/A11.1 $3.33
10/15/20224,920,000 shares $11.86 million -2.6%N/A12.2 $2.41
9/30/20225,050,000 shares $15.00 million -4.5%N/A15.2 $2.97
9/15/20225,290,000 shares $20.53 million +0.4%N/A16.8 $3.88
8/31/20225,270,000 shares $23.08 million +0.2%N/A15.6 $4.38
8/15/20225,260,000 shares $27.35 million -8.4%N/A14 $5.20
7/31/20225,740,000 shares $24.57 million -3.9%N/A13.3 $4.28
7/15/20225,970,000 shares $21.43 million +2.1%N/A11.6 $3.59
6/30/20225,850,000 shares $21.65 million -0.3%N/A11 $3.70
6/15/20225,870,000 shares $20.66 million +2.4%N/A10.4 $3.52
5/31/20225,730,000 shares $22.92 million +1.6%N/A10.8 $4.00
5/15/20225,640,000 shares $21.94 million -0.7%N/A10.6 $3.89
4/30/20225,680,000 shares $25.22 million +6.8%N/A10.1 $4.44
4/15/20225,320,000 shares $29.58 million -4.1%N/A9.1 $5.56
3/31/20225,550,000 shares $36.08 million -2.5%N/A9 $6.50
3/15/20225,690,000 shares $30.16 million -0.9%N/A9.2 $5.30
2/28/20225,740,000 shares $36.16 million -1.7%N/A8.4 $6.30
2/15/20225,840,000 shares $35.45 million +4.7%N/A8.2 $6.07
1/31/20225,580,000 shares $33.76 million +15.5%N/A8.3 $6.05
1/15/20224,830,000 shares $28.45 million +11.8%N/A7.8 $5.89
12/31/20214,320,000 shares $28.86 million +8.0%N/A7.2 $6.68
12/15/20214,000,000 shares $27.88 million +1.8%N/A6.7 $6.97
11/30/20213,930,000 shares $27.27 million -2.5%N/A7.6 $6.94
11/15/20214,030,000 shares $31.39 million -7.1%N/A7.6 $7.79
10/29/20214,340,000 shares $32.64 million +1.2%N/A8.7 $7.52
10/15/20214,290,000 shares $37.54 million -11.4%N/A9.3 $8.75
9/30/20214,840,000 shares $46.95 million -0.2%N/A11.3 $9.70
9/15/20214,850,000 shares $47.38 million +0.2%N/A11.5 $9.77
8/31/20214,840,000 shares $48.01 million -1.8%N/A10.5 $9.92
8/13/20214,930,000 shares $43.14 million -5.6%N/A11.3 $8.75
7/30/20215,220,000 shares $50.53 million +7.2%N/A11.3 $9.68
7/15/20214,870,000 shares $46.80 million -1.0%N/A9.2 $9.61
6/30/20214,920,000 shares $52.69 million +12.6%N/A9 $10.71
6/15/20214,370,000 shares $47.06 million +0.7%N/A7.6 $10.77
5/28/20214,340,000 shares $41.58 million +1.4%N/A7.3 $9.58
5/14/20214,280,000 shares $35.74 million +8.6%N/A6.1 $8.35

AKTS Short Interest - Frequently Asked Questions

Short interest is the volume of Aktis Oncology shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 7,250,000 shares of AKTS short. Learn More on Aktis Oncology's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKTS shares currently have a short interest ratio of 0.3. Learn More on Aktis Oncology's short interest ratio.

Aktis Oncology saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 7,250,000 shares, an increase of 101.9% from the previous total of 3,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aktis Oncology: Indivior PLC (11.51%), Crinetics Pharmaceuticals, Inc. (17.85%), Amneal Pharmaceuticals, Inc. (3.29%), Oruka Therapeutics, Inc. (14.65%), Viking Therapeutics, Inc. (21.06%), ACADIA Pharmaceuticals Inc. (8.76%), Tango Therapeutics, Inc. (24.75%), Travere Therapeutics, Inc. (12.13%), Twist Bioscience Corporation (18.38%), Catalyst Pharmaceuticals, Inc. (7.76%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper Company ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit Inc. ($2.00 billion). View all of the most shorted stocks.

Short selling AKTS is an investing strategy that aims to generate trading profit from Aktis Oncology as its price is falling. AKTS shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aktis Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKTS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKTS, twice per month. The most recent reporting period available is November, 30 2024.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AKTS:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:AKTS) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
May 13: The Fed Shock is about to hit the markets
Wall Street quantitative analyst Louis Navellier says a rare Federal Reserve regime change is opening a market...
Stansberry Research | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Elon’s “XG” Coming for $2 TRILLION Market?
SpaceX has announced plans to go public at a projected $1.5 trillion valuation - potentially 58 times larger t...
Paradigm Press | Sponsoredtc pixel